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ABSTRACT
Background: Coeliac disease is a small intestine
enteropathy caused by permanent intolerance to wheat
gluten. Gluten intake by patients with coeliac disease
provokes a strong reaction by intestinal intraepithelial
lymphocytes (IELs), which normalises on a gluten-free
diet.
Aim: To investigate whether impaired extrathymic T cell
maturation and/or secondary T cell receptor (TCR) gene
recombination in IELs are features of coeliac disease
which could contribute to the failure of establishing
tolerance to gluten.
Methods: Expression levels of the four splice-forms of
recombination activating gene-1 (RAG1) mRNA and preT
a-chain (preTa) mRNA were determined in IEL-subsets of
children with coeliac disease and controls. Frequencies of
RAG1 expressing IELs were determined by immunomor-
phometry.
Results: In controls, the RAG1-1A/2 splice-form selec-
tively expressed outside the thymus, was dominant and
expressed in both mature (TCR
+) and immature
(CD2
+CD7
+TCR
2) IELs (,8 mRNA copies/18S rRNA U).
PreTa was expressed almost exclusively in
CD2
+CD7
+TCR
2 IELs (,40 mRNA copies/18S rRNA U).
By contrast, RAG1 and preTa mRNA levels were low in
patients with coeliac disease compared to controls, both
with active disease and with inactive, symptom-free
disease on a gluten-free diet (p values ,0.01 for mature
and ,0.05 for immature IELs). Similarly, the frequencies
of RAG1+ IELs were significantly lower in patients with
coeliac disease compared to controls (p,0.001).
Conclusions: Patients with coeliac disease appear to
have an impaired capacity for extrathymic TCR gene
rearrangement. This is an inherent feature, which probably
plays a pivotal role in the failure to efficiently down-
regulate the T cell response to gluten.
Coeliac disease (CD) is a chronic inflammatory
disease of the small intestine affecting genetically
susceptible individuals carrying the HLA-DQ2 and/
or HLA-DQ8 alleles. It is caused by failure to
establish and/or maintain tolerance to dietary
prolamins in wheat, barley and rye, and particu-
larly to wheat gliadin.
1 Active disease is associated
with an intestinal lesion, typically showing villous
atrophy, crypt hyperplasia, and increased numbers
of lymphocytes within both the epithelium and
the lamina propria. Clinical and histological
improvements are seen upon withdrawal of wheat,
barley and rye from the diet.
2 A central role for T
lymphocytes in coeliac disease has long been
recognised,
3 and gliadin-specific T cell clones have
been isolated from the small intestinal mucosa of
patients with coeliac disease.
45
Accumulating evidence suggests an important
role for intraepithelial lymphocytes (IELs) in
coeliac disease pathogenesis. Human small intest-
inal IELs are composed of multiple T lymphocyte
subsets; the major subsets being CD4
+ and CD8
+
ab T cells, CD4CD8 double-negative cd T cells, and
cells with a thymocyte-like phenotype (CD1a
+
cells, CD2
+CD3
2 cells and CD4
+CD8
+ cells).
67
The numbers of both abIELs and cdIELs are
increased in the small intestine of patients with
coeliac disease, and although the number of abIELs
varies with disease activity, it is uncertain whether
this also is the case for cdIELs, which seem to stay
elevated longer after gluten has been withdrawn
from the diet.
8–10 In addition, the otherwise rare
CD8
+ IEL subtype expressing CD94, ie, one of the
two chains in several natural killer (NK)-cell
receptors, is increased in active coeliac disease.
11
Moreover, the increased production of interferon c
by T cells in active coeliac disease is most
pronounced in IELs,
12 and IELs from patients with
coeliac disease exhibit cytotoxicity regulated in an
NK-cell-like manner.
13–15
IELs in non-coeliac adults express recombination
activating gene-1 (RAG1) and pre T a-chain
(preTa) mRNAs.
16 Up to 6% of IELs expressed
the RAG1 protein, a finding that suggests ongoing
T cell receptor (TCR) gene rearrangement. The
human RAG1 gene has three different 59 untrans-
lated region (UTR) exons that generate four
different mRNA splice forms, two of which are
expressed exclusively outside the thymus.
16
We hypothesised that abrogated or decreased
T C Rr e c o m b i n a t i o n ,e i t h e ri nd en o v oe x t r a t h y m i c
T cell maturation or in TCR editing in mature T
cells, may negatively influence establishment and/or
maintenance of tolerance to food antigens.
Therefore, we compared expression levels of RAG1
mRNA splice forms and preTa mRNA in T cell
lineage subsets of IELs, using biopsies from children
with coeliac disease, both in active and inactive
disease, and from children with no food intolerance.
The frequencies of IELs expressing the RAG1 protein
were also compared between patients with coeliac
disease and controls. Coeliac disease is an excellent
human model for studies of this type since the
nominal antigen is known and inflammation ceases
upon its withdrawal from the diet. Thus, the
availability of intestinal biopsies from patients with
active and inactive disease allows discrimination
between genetically determined properties and
inflammation-dependent properties.
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Patients and biopsy sampling
Intestinal biopsies were collected from children admitted to the
Department of Pediatrics at Umea ˚ University Hospital on
suspicion of coeliac disease or for evaluation of asymptomatic
growth failure or short stature. Small intestinal biopsies were
collected from distal duodenum/proximal jejunum at the level
of the ligament of Treitz, using a Watson paediatric capsule.
Part of the biopsy sample was used for routine pathology
examination and grading by the Alexander score and the rest for
isolation of IELs or for immunohistochemistry. Biopsies were
immediately placed in ice-chilled HEPES-buffered RPMI 1640.
Patients were from three diagnostic groups, as follows.
c Active coeliac disease: children showing increased anti-
endomysium immunoglobulin A (IgA) (AEA) and/or anti-
gliadin IgA (AGA) antibody titres and a jejunal mucosa with
increased numbers of IELs and with villous atrophy and
crypt hyperplasia; all responding positively to a gluten-free
diet. (Nineteen children: six boys and 13 girls, median age
4.3 years (range, 1.3–17.0 years); AEA titres, 40 to >320;
Alexander scores, 2 (one child) and 3–4.)
c Treated coeliac disease: children with coeliac disease who had
been on a gluten-free diet for >11 months. (Thirteen
children: eight boys and five girls, median age 10.2 years
(range, 4.5–19.0 years); AEA titres, (20; Alexander score,
1.)
c Controls: children with no known food intolerance. (Twenty
children: 11 boys and nine girls, median age 3.5 years (range,
1.1–18.2 years); AEA titres, (20, Alexander score, 1.)
Oral informed consent was obtained from the patient and/or
the parents.
Cell isolation procedures
Intestinal IELs were isolated from small intestinal biopsies as
previously described.
12 The procedure includes pretreatment
with anti-CD11b mAb (clone OKM1; ATCC, Rockville,
Maryland, USA) charged paramagnetic beads (Dynabeads M-
450 coated with goat-anti-mouse IgG; Dynal, Oslo, Norway).
Subpopulations of IELs were thereafter retrieved by sequential
positive selection as depicted in fig 1, using paramagnetic beads
charged with anti-TCRcd mAbs (anti-Vd1 clone TS-8.2, anti-
TCRd-chain clone 5A6.E9 plus anti-TCRc-chain clone Y3.30; all
from Serotec, Kidlington, Oxford, UK), anti-TCRab mAb (clone
BMA031; Serotec), and finally, a mixture of beads charged with
anti-CD7 mAb (clone DK24; Dakopatts, Glostrup, Denmark)
and anti-CD2 directly coated on the beads (Dynal). Microscopic
inspection of all positively selected samples was performed to
ascertain that only cells with surface-bound beads were present.
The small amounts of cells in IEL subpopulations retrieved from
single biopsies precluded parallel RNA and phenotypical
analyses. However, previous studies have shown that fewer
than 4.6% of the respective surface marker-positive cells can be
found in the unbound fraction and that .98% of the marker-
positive cells were bound to the relevant beads using this
procedure.
71 21 6 The isolation procedure was started within
45 min following biopsy and performed at 4uC, and positively
selected cells were frozen within 1 h after exposure to mAb.
RNA preparation
Total RNA was extracted from the different cell preparations by
the acid guanidinium thiocyanate/phenol/chloroform method
and dissolved in RNase-free water containing rRNAsin ribonu-
clease inhibitor (Promega, Madison, Wisconsin, USA), as
described.
71 2
Real-time quantitative RT-PCR
Quantification of the 1A/2, 1B/2, 1A/1B/2, and 1C/2 splice forms
of RAG1 mRNA and the long isoform of preTa,p r e T a
a was
performed using real-time quantitative RT-PCR assays with RNA
copy standards constructed in the laboratory.
16 Samples were
analysed in triplicate and expressed as copies of mRNA per
microlitre. The concentration of 18S rRNA was determined in
each sample using real-time quantitative RT-PCR (Applied
Biosystems, Foster City, California, USA), and the results were
expressedasmRNAcopiesper18SrRNAU.One18SrRNAUwas
defined as the signal obtained by 10 pg of a pool of total RNA
extracted from peripheral blood mononuclear cells (PBMCs)
stimulated with anti-CD3 mAb, which corresponds to approxi-
mately 100 lymphocytes.
17 All samples included in the study
contained .19.5 U 18S rRNA per reaction mixture.
Cloning and sequencing
After gel electrophoresis, RT-PCR products for preTa
a mRNA
were isolated, ligated into EcoRV-digested pBluescript SK II(+)
prepared with a dT overhang, transformed into competent
Escherichia coli XL-1 Blue, cloned, and sequenced as previously
described.
16
Immunohistochemistry
Fresh tissue samples were snap frozen in liquid nitrogen and
stored at 280uC. Cryostat sections (8 mm thick) were air-dried,
Figure 1 Isolation procedure for intraepithelial lymphocyte (IEL) subtypes from intestinal biopsies. Rinsed tissue was treated with dithiothreitol and
vigorous shaking, and free intraepithelial cells were subjected to the selection procedure. First, cells of myeloid lineage and inherently sticky cells were
removed by treatment with anti-CD11b monoclonal antibody (mAb)-coated paramagnetic beads. Unbound cells (CD11b
2 cells) were collected and
subjected to sequential positive selection by incubation first with paramagnetic beads coated with a mixture of anti-TCRcd mAbs (cdIELs), followed by
incubation of unbound cells with paramagnetic beads coated with anti-TCRab mAb (abIELs), and finally incubation of unbound cells with a mixture of
anti-CD2 mAb and anti-CD7 mAb coated paramagnetic beads (CD2
+CD7
+IELs). RNA was subsequently extracted from the bound cell fractions.
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and then rinsed in cold 0.02 mol/l phosphate-buffered saline
(PBS, pH 7.4). Free aldehyde groups were blocked by incubation
with 0.1 mol/l glycine in PBS and sticky nuclear sites were
blocked by incubation with 10% acetic acid. Sections were
further blocked and membranes permeabilised by incubation
with PBS containing 0.2% bovine serum albumin/0.05%
saponin/0.1% Triton-X100 followed by incubation with 2.5%
normal horse serum (Vector Laboratories, Burlingame,
California, USA). Thereafter the sections were incubated for
1 h with the IgG fraction of rabbit anti-human RAG1 antiserum
(sc-5599; Santa Cruz Biotechnology, Santa Cruz, California,
USA) diluted in PBS containing 0.2% bovine serum albumin/
0.05% saponin/0.1% Triton-X100. Endogenous peroxidase
activity was blocked by incubation with 0.03% H2O2 and
13 mmol/l NaN3 at 37uC for 45 min. The slides were washed
and incubated for 60 min with ImmPress anti-rabbit Ig reagent
(Vector Laboratories). Positive cells were visualised by incuba-
tion with diaminobenzidine substrate and 0.03% H2O2 in
0.05 mol/l Tris–HCl buffer (pH 7.6). Finally, sections were
counterstained with methyl green and mounted in Canada
balsam. Sections incubated with concentration-matched IgG
fraction of normal rabbit serum (Dakopatts) served as negative
controls and sections incubated with the IgG fraction of rabbit
anti-human CD3 antiserum (Dakopatts) served as positive
controls. Morphometry was performed by inspecting the entire
section for stained IELs and measuring the total epithelial length
in the section by using an integrating, cooled colour 3CCD
camera (Colour Chilled 3 CCD Hamamatsu Camera C5810;
Hamamatsu Photonics, Hamamatsu City, Japan) on a standard
light microscope combined with an interactive computer image
analysis system (LeicaQWin; Leica Imaging Systems,
Cambridge, UK).
Statistics
Statistical analysis was performed using the Prism 4 computer
program (GraphPad Software, San Diego, California, USA).
Samples within groups were tested for Gaussian distribution by
the Kolmogorov–Smirnov normality test. Statistical analysis of
differences in RAG1 and preTa mRNA expression levels between
IEL subtypes and frequencies of RAG1
+ IELs in the three patient
groups was performed using one-way analysis of variance
(ANOVA) with the Bonferroni multiple comparison post-test. A
pv a l u e,0.05 was regarded as statistically significant.
RESULTS
T cell maturation and TCR editing normally occur in parallel
The expression patterns of RAG1 and preTa mRNAs in IELs
suggest that extrathymic T cell maturation and TCR editing/
Figure 2 Recombination activating gene 1A/2 (RAG1-1A/2) mRNA is the splice form preferentially expressed in small intestinal intraepithelial
lymphocytes (IELs) of children and is expressed at similar levels in both mature and immature IELs, while preTa mRNA is expressed at high levels only
in immature IELs. Expression levels of the 1A/2, 1B/2, and 1A/1B/2 RAG1 mRNA splice forms and preTa mRNA in cdIELs, abIELs, and CD2
+CD7
+IELs
retrieved from small intestinal biopsies of controls. p Values of statistically significant differences are depicted. Dots indicate expression levels for the
indicated mRNA species in individual IEL subtype samples. Horizontal bars indicate median values.
Table 1 Frequencies of recombination activating gene 1 (RAG1)
expressing intraepithelial lymphocytes (IELs) in the small intestinal
mucosa of patients with coeliac disease and in controls
Patient group Frequency of RAG1
+ IELs* n p Value
Controls 0.33 (0.11) 5
Active coeliac disease 0.05 (0.02) 6 ,0.001
Treated coeliac disease 0.06 (0.02) 5 ,0.001
n, number of samples counted.
p Values indicate statistically significant differences between patients with coeliac
disease and controls.
*Mean (1 SD) of number of RAG1
+ cells/mm epithelium.
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epithelium of children. IELs were isolated from small intestinal
biopsies and directly subjected to sequential positive selection,
as depicted in fig 1 and levels of the 1A/2, 1A/1B/2, 1B/2, and
1C/2 splice forms of RAG1 mRNA and the long isoform of
preTa were determined in the cdIELs, abIELs, and
CD2
+CD7
+IELs.
RAG1 mRNA was detected in all control IEL samples and in
all three subsets thereof. The RAG1-1A/2 splice form, which is
exclusively expressed outside the thymus, was expressed in the
highest concentrations, followed by the RAG1-1B/2 splice form
(fig 2). The long 1A/1B/2 splice form of RAG1 was detected
only in occasional samples (fig 2). There was no significant
difference in expression levels between the IEL subtypes. In
accordance with previous results,
16 the thymus-selective RAG1-
1C/2 splice form was not detected in any of the IEL subtypes
(n=3; data not shown).
As expected, preTa mRNA was mainly expressed in
immature CD2
+CD7
+IELs (median 36 copies per 18S rRNA U
compared to ,1 copy per 18S rRNA U in IELs expressing TCR;
fig 2). Cloning and sequencing of the RT-PCR products
confirmed the expected sequence of preTa mRNA.
Immunohistochemistry with anti-RAG1 antibodies revealed
presence of RAG1 positive IELs (table 1 and fig 3). The RAG1
+
cells exhibited a granular staining of the nucleus and showed an
irregular distribution in the tissue. Occasional villi harboured
small clusters of positive cells (fig 3A), while others had
scattered positive IELs alone (fig 3C) or in the vicinity of
RAG1
+ lamina propria lymphocytes (fig 3D) and yet other villi
were devoid of RAG1
+ cells (data not shown).
RAG1 expression is significantly decreased in IELs of patients
with coeliac disease
The expression levels of the four RAG1 mRNA splice forms
were also determined in cdIELs, abIELs, and CD2
+CD7
+IELs
isolated from intestinal biopsies of children with active, newly
diagnosed untreated coeliac disease (active coeliac disease) and
from symptom-free patients with coeliac disease on a gluten-
free diet (treated coeliac disease).
The expression levels of the RAG1-1A/2 mRNA splice form
were significantly reduced compared to controls in all three IEL
subsets of patients with coeliac disease both with active and
inactive disease (fig 4). For the two weakly expressed splice
forms, 1B/2 and 1A/1B/2, we found no significant difference
between patients with coeliac disease and controls in any of the
three IEL subsets (n=7–9 for each IEL subset in patients with
active and treated coeliac disease, respectively; data not shown).
The RAG1-1C/2 mRNA splice form was not detected in cdIELs,
abIELs, or CD2
+CD7
+IELs of patients with coeliac disease
neither with active (n=3) nor inactive disease (n=3; data
not shown).
In accordance with the low expression levels of RAG1 mRNA,
we found very few RAG1
+ IELs in the small intestine of children
with coeliac disease irrespective of disease activity (table 1). The
difference between patients with coeliac disease and controls
was statistically highly significant (table 1).
PreTa mRNA expression levels are also decreased in IELs of
patients with coeliac disease
cdIELs, abIELs, and CD2
+CD7
+IELs isolated from intestinal
biopsies of children with active coeliac disease and treated
Figure 3 Lymphocytes expressing the
recombination activating gene-1 (RAG1)
protein are normally present within the
small intestinal epithelium of children.
Immunoperoxidase staining of small
intestinal biopsies of two control patients
with anti-RAG1 rabbit immunoglobulin G
(IgG) (A,C,D). Cells with typical granular
staining of the nucleus can be seen in
villous epithelium (A), both villous
epithelium and lamina propria (C), and in
the lamina propria only (D). (B) Section
from the same patient as in (A) incubated
with IgG from normal rabbit serum.
Arrows indicate intraepithelial
lymphocytes (IELs) stained positively for
RAG1, and arrowheads indicate RAG1
+
cells in lamina propria. Original
magnification, 6220.
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mRNA. The preTa mRNA expression levels were significantly
lower in the CD2
+CD7
+IELs of patients with coeliac disease,
both in active and inactive disease, as compared to controls
(fig 5). The expression levels of preTa mRNA in cdIELs and
abIELs were low with no difference between any of the coeliac
disease groups and controls (fig 5).
DISCUSSION
The results support three major conclusions. First, simultaneous
expression of mRNAs for RAG1 and preTa, two proteins
transiently expressed during T cell maturation, in IELs with the
phenotype of immature T cell lineage cells (CD2
+CD7
+TCR
2)i n
controls suggests that extrathymic T cell maturation normally
occurs in the small intestinal epithelium of children. Taken
together with previous findings,
61 61 81 9 these results suggest
that extrathymic T cell maturation is a normal event in human
small intestinal mucosa throughout life.
Second, we found that the IELs with a more mature
phenotype, ie, abIELs and cdIELs also expressed RAG1 mRNA
suggesting ongoing TCR-gene rearrangement. The relatively
high levels of RAG1 mRNA in cdIELs and abIELs of children in
the control group strongly suggest an important role for TCR
revision by a secondary recombination of TCR gene segments in
T cells located within the intestinal epithelium early in life.
Most likely this reflects a T cell repertoire adaptation to the
particular small intestinal milieu with its complex demands of
effective protection without over-reaction to beneficiary com-
ponents, eg, food antigens.
Third, children with coeliac disease have significantly
decreased expression of both RAG1 in all three IEL-subtypes
and of preTa mRNA in immature T cells, suggesting reduced
extrathymic T cell maturation accompanied by decreased TCR
editing and/or revision. This reduction was independent of
disease activity, indicating that decreased T cell maturation in
the intestinal mucosa is an inherent property of patients with
coeliac disease. Thus, failure to adequately adapt the T cell
repertoire to the milieu at the intestinal mucosal surface and its
exposure to gluten peptides and the microbial flora might be an
important factor in the pathogenesis of coeliac disease.
Figure 4 Expression levels of the recombination activating gene-1
(RAG1)-1A/2 mRNA splice form are significantly decreased in patients
with coeliac disease. Expression levels of RAG1-1A/2 mRNA in cdIELs,
abIELs, and CD2
+CD7
+IELs freshly isolated from small intestinal biopsies
of controls and patients with coeliac disease with active disease (active
coeliac disease (Active CD)) and inactive disease (treated coeliac
disease (Treated CD)). p Values of statistically significant differences are
depicted. Dots indicate expression levels for the indicated mRNA species
in individual IEL subtype samples. Horizontal bars indicate median values.
IELs, intraepithelial lymphocytes.
Figure 5 PreTa mRNA expression levels are significantly decreased in
patients with coeliac disease. Expression levels of preTa mRNA in
cdIELs, abIELs, and CD2
+CD7
+IELs freshly isolated from small intestinal
biopsies of controls and patients with coeliac disease with active
disease (active coeliac disease (Active CD)) and inactive disease (treated
coeliac disease (Treated CD)). p Values of statistically significant
differences are depicted. Dots indicate expression levels for the indicated
mRNA species in individual IEL subtype samples. Horizontal bars indicate
median values. IELs, intraepithelial lymphocytes.
Coeliac disease
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small intestinal epithelium in patients with coeliac disease is
inherently different in comparison to the epithelium of control
individuals. As measured by lectin binding, patients with active
coeliac disease show a different glycosylation pattern on the
epithelial cells compared to controls and commonly have rod-
shaped bacteria adhered to the epithelial surface.
20 Patients with
coeliac disease also seem to exhibit a different intestinal
bacterial flora from controls, which persists on a gluten-free
diet.
21 Moreover, interferon c levels decrease in IELs of patients
with coeliac disease on a gluten-free diet; however, they seldom
reach the low levels in IELs of controls.
12 Furthermore, even
though cdIELs is a minor cell population among IELs, it remains
elevated for more than 1 year on a gluten-free diet.
10 These
results are compatible with the hypothesis that patients with
coeliac disease have insufficient defence at the epithelial surface
with poor discriminating capacity between pathogens and
beneficial components, possibly because of interdependent
differentiation of IELs and epithelial cell functions. A conse-
quence could be that gluten peptides are mistaken for
pathogens. The strong epithelial reaction with excessive
interferon c production by IELs and the presence of over-
stimulated intraepithelial cytotoxic T lymphocytes, which have
lost TCR restriction, are compatible with this idea.
12 15
Studies in mice
22–26 have shown that there are two types of T
cells maturing in the gut mucosa. These are precursor cells that
develop into cd T cells in the small intestine without thymic
influence and immature thymus emigrants that colonise the
small intestinal mucosa as T-cell-committed precursors and
mature into IELs locally. Thus, it is an open question whether
the immature IELs (CD2
+CD7
+TCR
2 cells) seen expressing
RAG1 and preTa mRNAs in the intestinal mucosa of children
are early emigrants from thymus or are thymus-independent
precursors of T cell lineage, or a mixture of both.
The significant reduction of the ‘‘extrathymic’’ RAG1-1A/2
splice form in both mature and immature T cell subsets and in
both active and inactive disease, suggests that the tissue-specific
signals required for involvement of the 1A exon in transcription
of the RAG1 gene are low or lacking in patients with coeliac
disease. The fact that both reduced RAG1 mRNA expression
and decreased frequencies of IELs expressing the RAG1 protein
is seen in both active disease and in inactive disease with
normalised mucosal histology argues against ‘‘dilution’’ of cells
undergoing TCR gene rearrangement with mature T cells
recruited in the gluten-induced intestinal reaction. Instead, it
underscores the likelihood that poor TCR gene rearrangement
in the intestinal mucosa is an inherent feature of patients with
coeliac disease. In line with our findings, Carton et al
27 reported
that the small CD4CD8 double positive IEL population, most
likely the immature IELs, is significantly decreased in patients
with coeliac disease, both in active and inactive disease.
Together these findings strongly support the notion that
defects in both extrathymic T cell maturation and TCR revision
in mature T cells, limit the possibilities of escaping unwanted
specificities against gluten epitopes and establishing tolerance in
patients with coeliac disease.
It has been reported that interleukin 2 (IL)2-deficient mice
have an impaired T cell lymphopoiesis in the gut and that the
intestinal inflammation seen in these mice was caused by
thymus-derived T cells.
28 It is possible that the local T cell
maturation also generates regulatory intestinal T cells in
humans, in which case the reduced extrathymic T cell
maturation in patients with coeliac disease would cause a
reduced capacity to downregulate gluten-reactive, thymus-
derived T cells in the intestinal mucosa.
In summary, it appears that reduced extrathymic T cell
maturation and TCR fine-tuning are contributing factors to the
inability to establish and maintain tolerance to gluten in
patients with coeliac disease.
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